Skip to main content
DeutschDE
European Commission logo print header

Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine

Ziel

Novel treatment options and associated personalised, patient-tailored therapies need to be explored and developed for highly heterogeneous and chemotherapy resistant cancers, such as malignant melanoma. This can only be achieved by industry-academia collaborations in newly emerging, innovative research disciplines such as translational cancer systems biology and systems medicine. These disciplines and the associated European training needs provide the foundation for the MEL-PLEX ETN. MEL-PLEX aims to understand the network-level and multi-scale regulation of disease-relevant signalling in melanoma through a combination of quantitative biomedical and computational research approaches that go significantly beyond the current state-of-the-art. Coordinated by the RCSI Centre for Systems Medicine, MEL-PLEX will train 15 early stage researchers through a highly interdisciplinary and intersectoral research training programme. MEL-PLEX comprises 11 beneficiaries and 7 partner organisations from 11 countries, including European and international leaders in personalised melanoma therapy, melanoma systems biology and cancer systems medicine. MEL-PLEX aims to (i) achieve an unmatched depth of molecular and mechanistic disease understanding, (ii) will exploit this knowledge to develop and validate predictive models for disease progression, prognosis and responsiveness to current and novel (co-)treatment options, and (iii) will provide superior and clinically relevant tools and biomarker signatures for personalising and optimising melanoma treatment. The MEL-PLEX ETN addresses current needs in academia and the private sector for researchers that have been trained in an environment that spans across biology, medicine and mathematics, that can navigate confidently between clinical, academic and private sector research environments, and that have developed an innovative and creative mindset to progress research findings towards applications.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

H2020-MSCA-ITN-2014

Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

MSCA-ITN-ETN - European Training Networks

Koordinator

ROYAL COLLEGE OF SURGEONS IN IRELAND
Netto-EU-Beitrag
€ 184 496,25
Adresse
ST STEPHEN'S GREEN 123
2 Dublin
Irland

Auf der Karte ansehen
Region
Ireland Northern and Western Border
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
€ 184 496,25

Beteiligte (11)

Partner (8)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 17 August 2022

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/642295/de

European Union, 2024